Overview
Shangzhi Xie practices practicing medicine in Hangzhou, China.
Their clinical expertise encompasses Cerebral Hypoxia, Hepatic Ischemia, Liver Cancer, and Non-Small Cell Lung Cancer (NSCLC).
They are actively involved in clinical research, co-authoring 29 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Shangzhi C. Xie
Is Shangzhi C. Xie a top-rated expert for Cerebral Hypoxia?
MediFind is an objective health platform that identifies experts based on real-world data. Shangzhi C. Xie is classified as an Experienced expert for Cerebral Hypoxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Shangzhi C. Xie participate in research or clinical trials?
Yes. Shangzhi C. Xie has published 29 articles and abstracts on conditions like Cerebral Hypoxia. You can view a list of Shangzhi C. Xie's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cerebral HypoxiaXie isExperienced. Learn about Cerebral Hypoxia.
- Hepatic IschemiaXie isExperienced. Learn about Hepatic Ischemia.
- Liver CancerXie isExperienced. Learn about Liver Cancer.
- Lung CancerXie isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)